Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ANK3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | ANK3 |
| Key Genes/Proteins | AND, CACNA1G, CAMK4, CANCER, CD8, ETV6 |
| Related Diseases | Autism, Bipolar, Cancer, Ms |
Knowledge base pages for this entity
graph TD
ANK3["ANK3"]
ANK3 -->|"inhibits"| Bipolar["Bipolar"]
ANK3 -->|"target for"| Ms["Ms"]
ANK3 -->|"target for"| Cancer["Cancer"]
ANK3 -->|"target for"| Tumor["Tumor"]
ANK3 -->|"inhibits"| Schizophrenia["Schizophrenia"]
ANK3 -->|"inhibits"| Autism["Autism"]
ANK3 -->|"activates"| ZBTB20["ZBTB20"]
ANK3 -->|"activates"| ETV6["ETV6"]
ETV6 -->|"activates"| ANK3
CAMK4["CAMK4"] -->|"activates"| ANK3
GENES["GENES"] -->|"activates"| ANK3
ZBTB20 -->|"activates"| ANK3
SETD1A["SETD1A"] -->|"inhibits"| ANK3
KMT2A["KMT2A"] -->|"inhibits"| ANK3
SHANK3["SHANK3"] -->|"inhibits"| ANK3| Target | Relation | Type | Str |
|---|---|---|---|
| Cancer | therapeutic_target | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Bipolar | inhibits | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Schizophrenia | inhibits | disease | 0.65 |
| Autism | inhibits | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| GENES | activates | gene | 0.60 |
| CANCER | associated_with | gene | 0.60 |
| ubiquitin-proteasome | participates_in | pathway | 0.60 |
| RNA | associated_with | gene | 0.60 |
| AND | activates | gene | 0.60 |
| T Cell | associated_with | cell_type | 0.60 |
| GAIN | expressed_in | gene | 0.60 |
| RNA | expressed_in | gene | 0.60 |
| KMT2B | inhibits | gene | 0.60 |
| SHANK3 | inhibits | gene | 0.60 |
| KMT2D | inhibits | gene | 0.60 |
| CACNA1G | inhibits | gene | 0.60 |
| KMT2A | inhibits | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| Ras | inhibits | protein | 0.60 |
| SETD1A | inhibits | gene | 0.60 |
| ZBTB20 | activates | gene | 0.60 |
| ETV6 | activates | gene | 0.60 |
| CAMK4 | activates | gene | 0.60 |
| SPP1 | associated_with | gene | 0.60 |
| CD8 | therapeutic_target | gene | 0.60 |
| SPP1 | therapeutic_target | gene | 0.60 |
| CD8 | associated_with | gene | 0.60 |
| TEX | expressed_in | cell_type | 0.56 |
| T Cell | expressed_in | cell_type | 0.55 |
| Source | Relation | Type | Str |
|---|---|---|---|
| SETD1A | inhibits | gene | 0.60 |
| SPP1 | associated_with | gene | 0.60 |
| CD8 | associated_with | gene | 0.60 |
| ETV6 | activates | gene | 0.60 |
| CAMK4 | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| ZBTB20 | activates | gene | 0.60 |
| RNA | associated_with | gene | 0.60 |
| CANCER | associated_with | gene | 0.60 |
| KMT2A | inhibits | gene | 0.60 |
| SHANK3 | inhibits | gene | 0.60 |
| GENES | inhibits | gene | 0.60 |
| CACNA1G | inhibits | gene | 0.60 |
| KMT2B | inhibits | gene | 0.60 |
| GAIN | expressed_in | gene | 0.60 |
| KMT2D | inhibits | gene | 0.60 |
| RNA | expressed_in | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning ANK3 in their description or question text
No additional research found